Marc Dunoyer

Chief Executive Officer

Marc Dunoyer is Chief Executive Officer of Alexion, AstraZeneca Rare Disease.

Headshot of Marc Dunoyer

About Marc

Marc previously served as an Executive Director and AstraZeneca’s Chief Financial Officer from November 2013. Marc’s career in pharmaceuticals, which has included periods with Roussel Uclaf, Hoechst Marion Roussel, and GSK, has given him extensive industry experience. He is a qualified accountant and joined AstraZeneca in 2013, serving as Executive Vice President, Global Product and Portfolio Strategy from June to October 2013. Prior to that, he served as Global Head of Rare Diseases at GSK and (concurrently) Chairman, GSK Japan. He holds an MBA from HEC Paris and a Bachelor of Law degree from Paris University.

Marc is a Director of Orchard Therapeutics Plc.

Jesse, diagnosed with gMG
I feel like tomorrow I can do something, whereas before, I didn’t feel like tomorrow was possible.”